Genzyme Sues Watson Over Renvela Powder ANDA
Genzyme Corp. has filed a patent infringement suit in an effort to block a Watson Pharmaceuticals Inc. unit from producing a generic version of kidney disease treatment Renvela in powder form,...To view the full article, register now.
Already a subscriber? Click here to view full article